The histories of Ireland and the U.S. are woven together into one tightly knit fabric laced with the green of the Emerald ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Plus, the National Academy of Sciences received $20 million, Agnes Scott College got $15 million, and three other ...

The first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

Merck is injecting $1 billion into a new facility in Wilmington, Delaware to amp up U.S. drug production, especially for its ...

Vertex Pharmaceuticals should continue to beat the market. Any time is a great time to buy stocks -- if you pick the right ...

These three stocks could potentially help investors create a stable – and growing – stream of passive income in the years ...

The game is afoot in the obesity space as GLP-1 rivals Eli Lilly and Novo Nordisk take their showdown to a new level. Lilly ...

Our writer explains why he just added to a big loser to his Stocks and Shares ISA portfolio, despite it going against one of ...